The Utility and Future for Strain Imaging in Cardio-Oncology

The Utility and Future for Strain Imaging in Cardio-Oncology

Washington University cardiologist, John Gorcsan, MD, discusses how echocardiographic strain imaging has emerged as an important noninvasive tool to assist in monitoring for chemotherapy cardiotoxicity. Global longitudinal strain (GLS) can be incorporated into the routine cardiac ultrasound examination and reported as an adjunct measure of left ventricular (LV) function. Data continues to build that GLS is additive to LV ejection fraction, and can provide additional prognostic information to patients being treated with cardiotoxic agents. Strain imaging is also useful to detect cardiac amyloidosis. A characteristic apical sparing pattern is observed where strain is more reduced at mid LV and basal LV levels. Strain imaging can be added to routine echo Doppler data, such as reduced early diastolic mitral annular velocities seen with cardiac amyloidosis. Because amyloidosis may be difficult to diagnose clinically, the addition of strain imaging may result in an increased diagnostic yield of patients with cardiac amyloidosis. 

View All Videos from Clinician’s Guide to Cardio-Oncology


Created by

Medical Professional Education Center

Presenters

John Gorcsan, MD

John Gorcsan, MD

Professor of Medicine,
Director of Clinical Research,
Washington University School of Medicine
St. Louis, MO

Education: B.A.: Lehigh University, Bethlehem, PA (1979) M.D.: Pennsylvania State University College of Medicine, Hershey, PA (1983)Internship and Residency: Hahnemann University Hospital, Philadelphia, PA (1983-1986) Fellowship: Geisinger ...